Jessica Tassan Analyst PerformanceSr. Research Analyst at Piper SandlerJessica Tassan is a stock analyst at Piper Sandler in the healthcare sector, covering 16 publicly traded companies. Over the past year, Jessica Tassan has issued 27 stock ratings, including buy and hold recommendations. While full access to Jessica Tassan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Jessica Tassan's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings43 Last 1 YearsBuy Recommendations78.05% 32 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution41RatingsDistribution of strong buy, buy, hold, and sell ratings by Jessica Tassan.RatingPercentageCount Strong Buy0.0%0 ratings Buy78.0%32 ratings Hold22.0%9 ratings Sell0.0%0 ratingsOut of 41 total stock ratings issued by Jessica Tassan at Piper Sandler, the majority (78.0%) have been Buy recommendations, followed by 22.0% Hold.Best & Worst CallsBest Call000.0%HNGEJun 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%EVHFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE68.8% of companies on NYSE11 companiesNASDAQ31.3% of companies on NASDAQ5 companiesJessica Tassan, an analyst at Piper Sandler, currently covers 16 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageHealthcare16 companies100.0%Jessica Tassan of Piper Sandler specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageHEALTHCARE PROVIDERS & SERVICES9 companies56.3%HEALTHCARE TECHNOLOGY6 companies37.5%HEALTHCARE EQUIPMENT & SUPPLIES1 company6.3% About Jessica TassanJessica Tassan is a vice president and senior research analyst at Piper Sandler with primary coverage of the healthcare IT & delivery sector. She joined Piper Sandler in 2016 as an equity sales associate covering the San Francisco market, with a focus on healthcare investors. Prior to Piper, Tassan spent time at UBS in San Francisco and New York. She graduated from the University of Connecticut, where she worked as an analyst at the Connecticut Center for Economic Analysis and earned bachelor's degrees in economics and political science. Tassan is based in San Francisco, where she keeps a finger on the pulse of trends in healthcare transformation and innovation.Follow on LinkedIn Jessica Tassan's Ratings History at Piper Sandler Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsOMCLOmnicell8/3/2026Reiterated Rating$36.90$45.00Overweight$0.0000.00% ROIHUMHumana7/30/2026Upgrade$367.67$463.00Overweight$0.0000.00% ROIUNHUnitedHealth Group7/16/2026Set Price Target$439.27$477.00$0.0000.00% ROICVSCVS Health6/1/2026Reiterated Rating$90.97$113.00Overweight$0.0000.00% ROIHUMHumana5/13/2026Reiterated Rating$295.34$254.00Neutral$0.0000.00% ROICVSCVS Health3/31/2026Lower Price Target$71.38$99.00Overweight$0.0000.00% ROICICigna Group3/3/2026Lower Price Target$282.46$370.00Overweight$0.0000.00% ROIPRVAPrivia Health Group2/26/2026Reiterated Rating$24.91$36.00Overweight$0.0000.00% ROITDOCTeladoc Health2/26/2026Reiterated Rating$5.09$9.00Overweight$0.0000.00% ROIDOCSDoximity2/20/2026Boost Price Target$25.22$42.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. OMCLOmnicell2/6/2026Reiterated Rating$39.08$49.00Overweight$0.0000.00% ROIDOCSDoximity2/6/2026Lower Price Target$33.30$40.00Overweight$0.0000.00% ROIUNHUnitedHealth Group1/27/2026Reiterated Rating$282.32Overweight$0.0000.00% ROIHNGEHinge Health1/9/2026Lower Price Target$49.40$60.00Overweight$0.0000.00% ROIALHCAlignment Healthcare1/6/2026Boost Price Target$21.00$30.00Overweight$0.0000.00% ROICVSCVS Health12/10/2025Reiterated Rating$78.31$101.00Overweight$0.0000.00% ROIEVHEvolent Health12/2/2025Set Price Target$3.89$6.00$0.0000.00% ROIOSCROscar Health11/25/2025Upgrade$16.72$25.00Overweight$0.0000.00% ROIPINCPremier11/5/2025Boost Price Target$28.16$28.25Neutral$0.0000.00% ROIHNGEHinge Health11/5/2025Reiterated Rating$47.00$71.00Overweight$0.0000.00% ROIUNHUnitedHealth Group10/28/2025Lower Price Target$368.74$417.00Overweight$0.0000.00% ROIPHRPhreesia9/5/2025Boost Price Target$31.31$34.00Overweight$0.0000.00% ROIEVHEvolent Health8/28/2025Boost Price Target$9.65$18.00Overweight$0.0000.00% ROIHCATHealth Catalyst8/27/2025Downgrade$3.50$4.00Neutral$0.0000.00% ROIPINCPremier8/25/2025Boost Price Target$25.50$28.00Neutral$0.0000.00% ROIOSCROscar Health8/14/2025Lower Price Target$14.61$13.00Neutral$0.0000.00% ROIDOCSDoximity8/11/2025Boost Price Target$66.71$69.00Overweight$0.0000.00% ROIHUMHumana7/31/2025Lower Price Target$255.66$272.00Neutral$000.0000.00% ROIUNHUnitedHealth Group7/30/2025Lower Price Target$260.86$317.00Overweight$000.0000.00% ROIHNGEHinge Health6/16/2025Initiated Coverage$34.76$41.00Overweight$00.0000.00% ROIOSCROscar Health6/9/2025Lower Price Target$15.41$18.00Overweight$00.0000.00% ROIUNHUnitedHealth Group6/3/2025Lower Price Target$302.22$353.00Overweight$000.0000.00% ROIAMWLAmerican Well5/23/2025Reiterated Rating$7.23$8.00Neutral$0.0000.00% ROIPINCPremier5/21/2025Boost Price Target$23.34$24.00Neutral$0.0000.00% ROICICigna Group5/5/2025Boost Price Target$333.66$374.00Overweight$000.0000.00% ROICVSCVS Health3/21/2025Boost Price Target$68.71$74.00Overweight$00.0000.00% ROIALHCAlignment Healthcare3/4/2025Boost Price Target$15.44$21.00Overweight$00.0000.00% ROITDOCTeladoc Health2/27/2025Lower Price Target$10.91$12.00Overweight$0.0000.00% ROIEVHEvolent Health2/21/2025Reiterated Rating$10.60$16.00Overweight$0.0000.00% ROIHCATHealth Catalyst2/11/2025Lower Price Target$5.75$8.00Overweight$0.0000.00% ROIFree Stock Pick: The Company First in Line for America’s New Super Fuel (Ad)The U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by President Trump to deploy a revolutionary new fuel. The first powerplant running this fuel is expected to go live before December 18, 2026. One obscure defense contractor already has a five-year head start on every competitor. The name, ticker symbol, and full story are being revealed at no cost.Click here to get the stock name, ticker, and full Project Janus details freePINCPremier2/5/2025Lower Price Target$19.12$19.00Neutral$0.0000.00% ROICICigna Group2/3/2025Reiterated Rating$294.59$348.00Overweight$000.0000.00% ROIPHRPhreesia1/29/2025Reiterated Rating$29.59$33.00Overweight$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerDeutsche Bank AktiengesellschaftBMO Capital MarketsMizuho Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
